Lilly Drug Jaypirca Delivers Positive Results in CLL Patients
Lilly’s Jaypirca showed a strong Progression-Free Survival (PFS) benefit in front-line CLL, with data from BRUIN studies set to support global label expansion filings.
Lilly Oncology | 10/09/2025 | By Dineshwori
Eli Lilly Announces Retirement of Anne White, Begins Search for Next Neuroscience Chief
Eli Lilly has announced that Anne White, Executive Vice President and President, Lilly Neuroscience, will retire from the company on December 31, 2025, after three decades of service.
Lilly Oncology | 21/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy